A new white paper from the American Gastroenterological Association calls for better risk assessment, more noninvasive testing options and targeted colonoscopy referrals to reduce colorectal cancer fatalities.
GI & Endoscopy
The FirstSightCRC blood-based multimodal colorectal cancer test could be inching its way closer to market, OncLive reports.
Here are six updates from gastroenterology companies and practices from the past week:
Gastroenterology has seen several partnerships arise since March 11, when the World Health Organization officially declared a pandemic.
Physician assistants can perform colonoscopies as accurately as gastroenterologists in average-risk patients, according to a study published in the Journal of the American Academy of Physician Assistants, reported on by Clinical Advisor.
CRH Medical Corp. acquired a majority interest in Orange County Anesthesia Associates, effective Aug. 3.
A July study published in Gut underscores the urgent need to head off "an impending cancer healthcare crisis," Medscape reports.
David Schwimmer, MD, joined Bradenton-based Florida Digestive Health Specialists.
Bausch Health agreed to pay the U.S. Securities and Exchange Commission $45 million to settle allegations it misled investors in reported financial figures during the 2014 and 2015 reporting periods.
Here are the five most-read Becker's ASC Review articles for gastroenterologists the week of July 27-31:
